Ideaya Biosciences (IDYA) Reiterated at Overweight by Cantor Fitzgerald

May 22, 2026 7:30 AM

Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented, "HARMONi-3 skepticism may be ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found